NSE · updated 17 Oct 2026, 12:01 am IST
From the exchange's bulk and block deal disclosures and NSE's daily file. The client's kind is read from its name. A record of trades, not a view on them. All big deals →
Hester Biosciences Limited trades on the NSE under the symbol HESTERBIO. NSE's securities master records its listing date as 13 Mar 2015.
On 16 Oct 2026 the stock closed at ₹2,236.5, +1.8% on the day. Over the past year it has traded between ₹1,254.5 and ₹2,673.15; the current price sits 69% of the way up that range, 16.3% below the 52-week high. The move has been +8.6% over five sessions, +1.9% over a month, -5.5% over three months, +36.9% over six months.
Volume in the last session was 1.0× the stock's 20-session average. 43% of that volume was taken as delivery, against a 20-session average of 52%.
No promoter or insider trades have been filed for the stock in the last 90 days. No bulk or block deals were disclosed in the last 30 days.
| Face value | ₹10 |
| ISIN | INE782E01017 |
| 52-week range | ₹1,254.5 – ₹2,673.15 |
| 1-month return | +1.9% |
| 3-month return | -5.5% |
| 6-month return | +36.9% |
| Delivery (last session) | 43% (avg 52%) |
| Insider filings (90d) | 0 buy / 0 sell |
| Disclosed deals (30d) | 0 buy / 0 sell |
The US is the largest single export market for Indian drugmakers. Most of what they ship there is generics, and the Commerce Department said generics and their ingredients fall outside the Section 232 tariff. That…
Close price
Delivery % · 30-session average 47.8%
Delivery is the share of traded volume actually settled into demat accounts rather than squared off intraday — the difference between accumulation and churn. How it is used.
Exchange-disclosed transactions, reported as published.
| Date | Client | Type | Qty | Price | Value |
|---|---|---|---|---|---|
| No deals disclosed. | |||||